CLINICAL SAFETY AND DRUG INTERACTIONS WITH 8-AMINOQUINOLINES

H. Myint; Colin Ohrt; Aruna Sampath; LA Walker; Sir Nicholas White; Alan J. Magill

Related publications

Article1991

Interleukin-8 and malaria

Jon S. Friedland, M. Ho, D Remick, D Bunnag, Sir Nicholas White, GE Griffin

Cytokine

Article1977

ChemInform Abstract: CHEMICAL CONSEQUENCES OF ORBITAL INTERACTIONS. 8. THE IMPORTANCE OF THE COUNTERION. THE RELATIVE ENERGIES OF HOMOCUBYL CATIONS AND ION PAIRS

William L. Jorgensen

Chemischer Informationsdienst

Chapter in a book2021

Interactions of Peptides with Lipid Bilayers

Stephen H. White, Gunnar Von Heijne, Donald M. Engelman

Article2010

DOES THE SECOND GENERATION OCT IMPROVE SAFETY AND FEASIBILITY IN CLINICAL PRACTICE? A SINGLE CENTER EXPERIENCE

Takayuki Okamura, Nieves Gonzalo, Patrick W. Serruys, Robert‐Jan van Geuns, Willem J. van der Giessen, Jürgen Ligthart, Gijs van Soest, Guillermo J. Tearney, Brett E. Bouma, Evelyn Regar

Journal of the American College of Cardiology

Article2013

POOLED ANALYSIS OF LONG–TERM SAFETY DATA FROM THE RESOLUTE CLINICAL TRIAL PROGRAM

Ganesh Manoharan, Franz‐Josef Neumann, Stephan Windecker, Martin B. Leon, Ian T. Meredith, Shigeru Saito, Patrick W. Serruys, Sigmund Silber, Alan C. Yeung, Jorge Belardi, Petr Widimský, Laura Mauri